Tetraphase Pharmaceuticals Announces Closing of Public Offering of Common Stock
March 17, 2015 12:25 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., March 17, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH) today announced the closing of its underwritten public offering of 4,945,000 shares of common stock...
Tetraphase Pharmaceuticals Announces Pricing of Public Offering of Common Stock
March 11, 2015 18:27 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., March 11, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH) today announced the pricing of an underwritten public offering of 4,300,000 shares of common stock...
Tetraphase Pharmaceuticals Announces Proposed Public Offering of Common Stock
March 09, 2015 16:49 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., March 9, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH) today announced that it intends to offer and sell up to 3,500,000 shares of its common stock in an...
Tetraphase Pharmaceuticals Reports Fourth-Quarter and Full-Year 2014 Financial Results
March 05, 2015 16:01 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., March 5, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior Vice President and General Counsel
March 05, 2015 07:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., March 5, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase to Host Conference Call Discussing Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights
February 26, 2015 16:05 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences
February 04, 2015 07:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Feb. 4, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...